.jpg)
.jpg)
Recommended
November 05, 2025
Enova Advanced® EDoF IOL: Next-Generation Vision with Light Tailoring Technology
The Enova Advanced® Extended Depth of Focus (EDoF) IOL, developed by VSY Biotechnology GmbH, represents a significant evolution in intraocular lens technology.
Breaking News
FDA Approves Glaukos' Epioxa: First Incision-Free Corneal Cross-Linking Therapy for Keratoconus
Oct 21, 2025
The U.S. Food and Drug Administration (FDA) has approved Glaukos’ New Drug Application (NDA) for Epioxa HD/Epioxa, marking a breakthrough in the treatment of keratoconus.
FDA Approves Celltrion’s Eylea Biosimilar Eydenzelt for Retinal Diseases
Oct 13, 2025
The U.S. Food and Drug Administration (FDA) has approved Eydenzelt (aflibercept-boav), a biosimilar referencing Eylea (aflibercept), developed by Celltrion.
FDA Approves Amneal Pharmaceuticals’ Generic Bimatoprost 0.01% for Glaucoma and Ocular Hypertension
Sep 25, 2025
Amneal Pharmaceuticals has received FDA approval for its Abbreviated New Drug Application (ANDA) for bimatoprost ophthalmic solution 0.01%, marking the company’s latest addition to its Affordable Medicines portfolio.
.jpg)
Industry News
Kodiak Sciences Shares Positive 20-Week Results from APEX Study of KSI-101 for MESI
Nov 10, 2025
Kodiak Sciences has released 20-week follow-up data from the APEX study, evaluating KSI-101 in patients with macular edema secondary to inflammation (MESI).
PolyActiva and RareSight Partner on Pediatric Retinal Disease Therapies
Nov 10, 2025
PolyActiva and RareSight have officially announced a strategic research collaboration to develop first-in-class therapies for rare pediatric retinal diseases, specifically targeting conditions that currently have no approved drug treatments.
Santen Secures UK MHRA Approval for Ryjunea to Slow Myopia Progression in Children
Nov 07, 2025
Sydnexis has announced that its partner, Santen, has received regulatory approval from the UK Medicines and Healthcare products Regulatory Agency (MHRA) for Ryjunea.
Ophthalmic Research News
Laser Heat Therapy Shows Potential to Halt Progression of Dry Macular Degeneration
Nov 10, 2025
A team of researchers from Aalto University has introduced a promising laser heat treatment for dry age-related macular degeneration (AMD), potentially offering a new way to stop the disease's progression if applied during the early diagnosis phase.
Study Reveals Novel Molecular Mechanisms Shaping Retinal Neuron Identity
Oct 31, 2025
A study led by Tiffany Schmidt, Ph.D., Associate Professor of Ophthalmology and Neurobiology at the Weinberg College of Arts and Sciences, has uncovered previously unknown cellular mechanisms that define neuron identity in retinal cells.
Early Protein Trigger of Diabetic Retinopathy Identified by UCL Scientists
Oct 27, 2025
A groundbreaking study led by researchers at the UCL Institute of Ophthalmology has identified a key protein that plays a critical role in the early development of diabetic retinopathy, a leading cause of vision loss among working-age adults.
Ophthalmic Blog
AI in Ophthalmology: Top Artificial Intelligence Tools Transforming Eye Health
Mar 07, 2025
The AI in ophthalmology sector is evolving rapidly, introducing Artificial Intelligence tools in ophthalmology that enhance diagnostic accuracy, efficiency, and accessibility.
2024 Recap: Top 8 Groundbreaking Innovations in Eye Disease Therapies and Technologies
Dec 23, 2024
The year 2024 has been a remarkable period for advancements in ophthalmology, with groundbreaking innovations reshaping the landscape of eye disease treatment and diagnosis.
2024 Recap: Top 8 FDA Approvals in Ophthalmology
Dec 16, 2024
The year 2024 has been a pivotal one for ophthalmology, with several novel FDA approvals introducing innovative treatments and technologies to the field
Ophthalmology Breaking News Subscribe